Brief: AnaptysBio Q1 Net Income USD -43.936 Million
09/05/2024 21:15
May 09 (Reuters) - AnaptysBio Q1 operating expenses USD 49.38 million. * Q1 collaboration revenue USD 7.179 million * Q1 income from operations USD -42.201 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged